Annual Current Liabilities
$26.64 M
-$6.71 M-20.13%
December 31, 2023
Summary
- As of February 21, 2025, VRDN annual total current liabilities is $26.64 million, with the most recent change of -$6.71 million (-20.13%) on December 31, 2023.
- During the last 3 years, VRDN annual current liabilities has risen by +$15.96 million (+149.53%).
- VRDN annual current liabilities is now -20.13% below its all-time high of $33.35 million, reached on December 31, 2022.
Performance
VRDN Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$41.36 M
+$4.60 M+12.52%
September 30, 2024
Summary
- As of February 21, 2025, VRDN quarterly total current liabilities is $41.36 million, with the most recent change of +$4.60 million (+12.52%) on September 30, 2024.
- Over the past year, VRDN quarterly current liabilities has increased by +$18.12 million (+77.93%).
- VRDN quarterly current liabilities is now at all-time high.
Performance
VRDN Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
VRDN Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.1% | +77.9% |
| 3 y3 years | +149.5% | +77.9% |
| 5 y5 years | +295.6% | +77.9% |
VRDN Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -20.1% | +95.3% | at high | +203.3% |
| 5 y | 5-year | -20.1% | +161.6% | at high | +515.3% |
| alltime | all time | -20.1% | +1239.1% | at high | +2313.0% |
Viridian Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $41.36 M(+12.5%) |
| Jun 2024 | - | $36.76 M(+40.7%) |
| Mar 2024 | - | $26.13 M(-1.9%) |
| Dec 2023 | $26.64 M(-20.1%) | $26.64 M(+14.6%) |
| Sep 2023 | - | $23.25 M(-18.9%) |
| Jun 2023 | - | $28.66 M(-3.1%) |
| Mar 2023 | - | $29.59 M(-11.3%) |
| Dec 2022 | $33.35 M(+144.6%) | $33.35 M(+32.3%) |
| Sep 2022 | - | $25.21 M(+17.9%) |
| Jun 2022 | - | $21.39 M(+48.7%) |
| Mar 2022 | - | $14.39 M(+5.5%) |
| Dec 2021 | $13.64 M(+27.7%) | $13.64 M(-4.9%) |
| Sep 2021 | - | $14.34 M(-14.8%) |
| Jun 2021 | - | $16.83 M(+2.4%) |
| Mar 2021 | - | $16.44 M(+54.0%) |
| Dec 2020 | $10.67 M(+4.9%) | $10.67 M(+41.2%) |
| Sep 2020 | - | $7.56 M(+12.4%) |
| Jun 2020 | - | $6.72 M(-22.4%) |
| Mar 2020 | - | $8.66 M(-14.9%) |
| Dec 2019 | $10.18 M | $10.18 M(-2.0%) |
| Sep 2019 | - | $10.38 M(+13.5%) |
| Jun 2019 | - | $9.15 M(+33.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $6.86 M(+1.9%) |
| Dec 2018 | $6.73 M(+72.8%) | $6.73 M(-1.5%) |
| Sep 2018 | - | $6.83 M(+59.5%) |
| Jun 2018 | - | $4.28 M(+3.6%) |
| Mar 2018 | - | $4.14 M(+6.2%) |
| Dec 2017 | $3.90 M(-15.0%) | $3.90 M(-40.4%) |
| Sep 2017 | - | $6.53 M(-1.4%) |
| Jun 2017 | - | $6.63 M(-8.9%) |
| Mar 2017 | - | $7.28 M(+58.8%) |
| Dec 2016 | $4.58 M(+85.8%) | $4.58 M(+60.7%) |
| Sep 2016 | - | $2.85 M(+9.9%) |
| Jun 2016 | - | $2.60 M(+6.3%) |
| Mar 2016 | - | $2.44 M(-1.0%) |
| Dec 2015 | $2.47 M(+24.1%) | $2.47 M(+16.7%) |
| Sep 2015 | - | $2.11 M(+1.9%) |
| Jun 2015 | - | $2.08 M(-16.8%) |
| Mar 2015 | - | $2.50 M(+25.4%) |
| Dec 2014 | $1.99 M(-92.7%) | $1.99 M(-0.3%) |
| Sep 2014 | - | $2.00 M(-6.7%) |
| Jun 2014 | - | $2.14 M(+24.7%) |
| Mar 2014 | - | $1.71 M(-93.7%) |
| Dec 2013 | $27.30 M(+15.7%) | $27.30 M |
| Dec 2012 | $23.60 M | - |
FAQ
- What is Viridian Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Viridian Therapeutics?
- What is Viridian Therapeutics annual current liabilities year-on-year change?
- What is Viridian Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Viridian Therapeutics?
- What is Viridian Therapeutics quarterly current liabilities year-on-year change?
What is Viridian Therapeutics annual total current liabilities?
The current annual current liabilities of VRDN is $26.64 M
What is the all time high annual current liabilities for Viridian Therapeutics?
Viridian Therapeutics all-time high annual total current liabilities is $33.35 M
What is Viridian Therapeutics annual current liabilities year-on-year change?
Over the past year, VRDN annual total current liabilities has changed by -$6.71 M (-20.13%)
What is Viridian Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of VRDN is $41.36 M
What is the all time high quarterly current liabilities for Viridian Therapeutics?
Viridian Therapeutics all-time high quarterly total current liabilities is $41.36 M
What is Viridian Therapeutics quarterly current liabilities year-on-year change?
Over the past year, VRDN quarterly total current liabilities has changed by +$18.12 M (+77.93%)